Bellinger Andrew

Track

Insider profile

Bellinger Andrew's trades of Verve Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
475.07
Quantity 97,550 -13.7%
Value US$4,396,544
Transaction date
Planned sale
Price
35.31
Quantity 36,798 -78.9%
Value US$1,299,304
Transaction date
Purchase
Price
19.00
Quantity 5,000 +inf%
Value US$95,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-12-02 2022-12-01
PlS Planned sale
9,421 -31.1%
56.24
US$4,488,892 		9,421 -31.1% 56.24 US$4,488,892
2022-11-01 2022-10-28
PlS Planned sale
97,550 -13.7%
475.07
US$4,396,544 		97,550 -13.7% 475.07 US$4,396,544
2022-09-27 2022-09-23
PlS Planned sale
28,280 -10.3%
384.15
US$802,951 		28,280 -10.3% 384.15 US$802,951
2022-09-27 2022-09-23
PlS Planned sale
36,798 -78.9%
35.31
US$1,299,304 		36,798 -78.9% 35.31 US$1,299,304
2022-09-27 2022-09-23
PlS Planned sale
13,368 -66.9%
35.59
US$475,803 		13,368 -66.9% 35.59 US$475,803
2022-09-27 2022-09-23
PlS Planned sale
6,632 -24.9%
34.67
US$229,905 		6,632 -24.9% 34.67 US$229,905
2022-07-22 2022-07-20
PlS Planned sale
20,000 -75.1%
34.90
US$698,000 		20,000 -75.1% 34.90 US$698,000
2022-07-15 2022-07-13
PlS Planned sale
10,000 -60.1%
24.90
US$249,000 		10,000 -60.1% 24.90 US$249,000
2021-06-21 2021-06-21
B Purchase
5,000 +inf%
19.00
US$95,000 		5,000 +inf% 19.00 US$95,000